insense medical develops state of the art respiratory support technology as an alternative to mechanical ventilation by 2020 more than 600,000 patients in the u.s. will require mechanical ventilation. 5.7 million patients are admitted annually to icu's with 35% needing ventilation. cost of treatment is estimated at 64 bn$/y as mortality reaches 40%. imagine that instead of mechanical ventilation, or ecmo treatment, a small and safe apparatus is placed into a vein, replacing necessary lung functions without the devastating complications associated with mechanical ventilation. oxylink, an advanced nano vesicle technology. our revolutionary intravascular oxygenation apparatus, safely increases the level of oxygen & reduces the carbon dioxide in blood, enabling your physician to address the primary ventilatory condition.